Literature DB >> 11416833

Epidemiology of erectile dysfunction: results of the 'Cologne Male Survey'.

M Braun1, G Wassmer, T Klotz, B Reifenrath, M Mathers, U Engelmann.   

Abstract

The last few decades have seen a marked increase in mean life expectancy in Central Europe. This has made elderly people and their quality of life a matter of ever-increasing medical concern. Available data from the United States and Scandinavia relating to erectile dysfunction (ED) do not enable us to draw valid conclusions about the current situation in Germany. The aim of the present study was to evaluate the epidemiology of male sexuality in Germany, and the proportion of men who need medical treatment because of increased suffering from this.A newly developed and validated questionnaire on male erectile dysfunction was mailed to a representative population sample of 8000 men, 30-80 y of age in the Cologne urban district. The response included 4489 evaluable replies (56.1%). The response rates in different age groups ranged from 49.2% to 68.4%. Regular sexual activity was reported by 96.0% (youngest age group) to 71.3% (oldest group). There were 31.5%-44% of responders who were dissatisfied with their current sex life. The prevalence of ED was 19.2%, with a steep age-related increase (2.3-53.4%) and a high co-morbidity of ED with hypertension, diabetes, pelvic surgery and 'lower urinary tract symptoms'. When treatment need was defined by co-occurrence of ED and dissatisfaction with sex life, 6.9% men required treatment for ED. Oral treatment of ED was preferred by 73.8% of respondents. There were 46.2% respondents who were willing to contribute more than DM 50 (25 Euro) per month for ED treatment. We conclude that regular sexual activity is a normal finding in advanced age. ED is a frequent disorder, contributing to dissatisfaction with sex life in a considerable proportion of men. The high burden of ED is reflected in willingness to pay for treatment. ED is frequently associated with chronic diseases. Therefore adequate diagnostic workup is essential, to offer patients individually adapted treatment. General non-reimbursability of treatment for ED appears to be unacceptable.

Entities:  

Mesh:

Year:  2000        PMID: 11416833     DOI: 10.1038/sj.ijir.3900622

Source DB:  PubMed          Journal:  Int J Impot Res        ISSN: 0955-9930            Impact factor:   2.896


  159 in total

Review 1.  Drug treatments for lower urinary tract symptoms secondary to bladder outflow obstruction: focus on quality of life.

Authors:  Donald MacDonald; Thomas A McNicholas
Journal:  Drugs       Date:  2003       Impact factor: 9.546

Review 2.  [Erectile dysfunction. New drugs with special consideration of the PDE 5 inhibitors].

Authors:  H Porst
Journal:  Urologe A       Date:  2004-07       Impact factor: 0.639

Review 3.  Epidemiology of erectile dysfunction.

Authors:  Stanley G Korenman
Journal:  Endocrine       Date:  2004 Mar-Apr       Impact factor: 3.633

Review 4.  [Symptoms or complaints in the aging male--which questionnaires are available?].

Authors:  M E Beutel; H Schneider; W Weidner
Journal:  Urologe A       Date:  2004-09       Impact factor: 0.639

5.  The importance of psychosexual counselling in the re-establishment of organic and erotic functions after penile prosthesis implantation.

Authors:  F Pisano; M Falcone; A Abbona; M Oderda; F Soria; F Peraldo; F Marson; M Barale; C Fiorito; A Gurioli; B Frea; P Gontero
Journal:  Int J Impot Res       Date:  2015-08-13       Impact factor: 2.896

6.  Current Diagnosis and Management of Erectile Dysfunction.

Authors:  Alexander W Pastuszak
Journal:  Curr Sex Health Rep       Date:  2014-09

7.  Sexual quality of life is impaired in patients with chronic hepatitis C.

Authors:  J Vergniol; S Duc; G Hou; J B Hiriart; J Foucher; F Chenus; C Fabères; F Chermak; A Lafournière; N Souakri; V de Lédinghen
Journal:  Int J Impot Res       Date:  2016-02-11       Impact factor: 2.896

8.  Men's aging and sexual disorders: an update on diagnosis and treatment.

Authors:  Alvaro Morales
Journal:  Rev Endocr Metab Disord       Date:  2005-05       Impact factor: 6.514

9.  [Clinical drug research in German urology from the viewpoint of a sponsor].

Authors:  M Burkart
Journal:  Urologe A       Date:  2006-09       Impact factor: 0.639

10.  Golombok Rust Inventory of Sexual Satisfaction for the presence of sexual dysfunction within a Ghanaian urological population.

Authors:  N Amidu; L Quaye; A A Afoko; P Karikari; B B N Gandau; E O Amoah; E Nuwoku
Journal:  Int J Impot Res       Date:  2014-01-16       Impact factor: 2.896

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.